• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

  • Home
  • About Us
    • Mission and History
    • Grace-Marie Turner bio
    • Who was Galen?
  • Activities
    • Core Activities
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Contact Us
  • Major Papers
  • Broadcast Interviews
  • Health Policy Consensus Group

Published

Folly And Waste — Brian Blase In Forbes

POSTED BY Galen Institute on October 20, 2021.

CBO Confirms the Folly and Waste of Expanded Obamacare Subsidies by Brian Blase | Forbes, October 20, 2021 |  A new report from the Congressional Budget Office (CBO) shows that expanding Affordable Care Act (ACA) subsidies is poor public policy.CBO projects that expanding the ACA, which includes increased premium subsidies for exchange insurance as well as a new federal Medicaid … [Read more...] about Folly And Waste — Brian Blase In Forbes

Filed Under: Brian Blase, Forbes

“Tough” Choices for Dems — Brian Blase in NRO

POSTED BY Galen Institute on October 13, 2021.

What to Cut? Start with the Subsidies to Health-Insurance CompaniesBy Brian BlaseNational Review Online, Oct. 12, 2021 The news is full of stories about the “tough” choices that congressional Democrats must make to trim their massive $3.5 trillion reconciliation package. Here’s an easy one — eliminate the $600 billion in subsidies to health-insurance companies in the proposed legislation, Galen … [Read more...] about “Tough” Choices for Dems — Brian Blase in NRO

Filed Under: Brian Blase, National Review

Drug Price Controls Threaten Biotech Research and Patients

POSTED BY Grace-Marie Turner on September 22, 2021.

There are too many dreadful provisions in Democrats’ $3.5 trillion spending monstrosity to count, but one is rising to the surface as especially destructive. That would be its prescription drug price-control schemes. A study by University of Chicago economist Tomas Philipson and analyst Troy Durie concludes that the Congressional Budget Office is wrong by more than an order of … [Read more...] about Drug Price Controls Threaten Biotech Research and Patients

Filed Under: Grace-Marie Turner, The Daily Signal

Medicaid Blowout

POSTED BY Brian Blase on September 22, 2021.

“Medicaid now covers 1 in 4 Americans, but Congress may soon lock even more into an expensive program with inadequate access to doctors and poor health outcomes,” Brian Blase writes today in a Wall Street Journal op-ed, “The Next Medicaid Blowout.” “One section of the $3.5 trillion bill Democrats are trying to push through Congress would create a new federal Medicaid program to cover mainly … [Read more...] about Medicaid Blowout

Filed Under: Brian Blase, The Wall Street Journal

Rethink The Child Mask Mandate — Doug Badger for Daily Signal

POSTED BY Galen Institute on September 1, 2021.

CDC Should Revise Its Guidance Mandating Masks at School By Doug Badger August 31, 2021  The Daily Signal The Centers for Disease Control and Prevention recommends “universal indoor masking of all students age 2 and older.” But there’s just one problem: The leading study on which the CDC bases this recommendation found that the COVID-19 infection rate in … [Read more...] about Rethink The Child Mask Mandate — Doug Badger for Daily Signal

Filed Under: Doug Badger, The Daily Signal

“Vax Shaming”

POSTED BY Galen Institute on August 2, 2021.

President Biden yesterday warned governors to “get out of the way of the people that are trying to do the right thing” by imposing new mask mandates, requiring vaccine passports, and other COVID restrictions. Biden called out Florida Gov. Ron DeSantis and Texas Gov. Greg Abbott, pointedly noting their states account for one-third of all new cases.  DeSantis pushed back, saying … [Read more...] about “Vax Shaming”

Filed Under: Doug Badger, The Daily Signal

Unmasking Washington’s Role In COVID

POSTED BY Galen Institute on July 27, 2021.

Was America’s federalist system of government an asset or liability during the COVID-19 pandemic?  Doug Badger and Bob Moffit conclude, based upon ample evidence, that it was a benefit that “fostered policy innovation, enabled state officials to avoid misguided measures,” and resulted in better economic outcomes.   In their new Heritage paper, “Health Care Reform COVID-19 … [Read more...] about Unmasking Washington’s Role In COVID

Filed Under: Doug Badger, The Heritage Foundation

Examining The Affordable Care Act’s Effect On Coverage

POSTED BY Galen Institute on July 20, 2021.

A recent report released by the Department of Health and Human Services claims that 31 million Americans were enrolled in coverage related to the Affordable Care Act (ACA). Without proper context, this number is misleading and is being misinterpreted. Here is what you need to know: There has been virtually no change in private health insurance coverage because of the … [Read more...] about Examining The Affordable Care Act’s Effect On Coverage

Filed Under: Brian Blase, Health Affairs

« Previous Page
Next Page »

Primary Sidebar

Our Annual Report

Health Care Choices 20/20:

A Vision for the Future

SEARCH

Categories

  • Brian Blase
  • Consumer-Directed Care
  • Doug Badger
  • Grace-Marie Turner
  • Health Insurance
  • Health Policy Consensus Group
  • Health Savings Accounts
  • Innovation
  • Medicaid
  • Medicare
  • Newsletter
  • ObamaCare
  • Prescription Drugs
  • Published
    • Forbes
    • Fox Business
    • Health Affairs
    • LA Times
    • National Review
    • New York Post
    • RealClearHealth
    • Sun Sentinel
    • The Daily Signal
    • The Heritage Foundation
    • The Hill
    • The New York Times
    • The Wall Street Journal
    • The Washington Times
  • Reform Initiatives
  • State Issues
  • Uncategorized

LATEST NEWSLETTER ISSUES

SUBSCRIBE

Social Media

Like Us On Facebook

Twitter: @galeninstitute

 

Copyright Galen Institute at Donors. © 2023; · Log in